SEP 4, 2026 · JOURNAL ARTICLE
Supramolecular immunomodulatory hydrogelator potentiates CAR-T therapy with long-lasting endogenous immunity toward solid tumor eradication
Science Advances
Preclinical mechanistic study in murine tumor models demonstrating a novel hydrogel delivery platform; no human data, clinical outcomes, or comparative efficacy data reported.
Study details
DesignPreclinical in vivo study in murine tumor m…
InterventionIn situ hydrogel scaffold co-delivering CAR…